The Food and Drug Administration said yesterday that it is making changes in the way it operates to prevent the kind of drug safety controversies that have dogged the agency in recent years.
The U.S. Food and Drug Administration announced Tuesday that it will improve drug safety by issuing “report cards” detailing unexpected side effects that crop up after drugs are approved and upgrading an electronic database that tracks reports of drug problems.
WASHINGTON (Reuters) — The Food and Drug Administration will upgrade a database and make organizational changes to better detect potential drug risks that emerge after medicines reach the market, the agency said Tuesday.
WASHINGTON — The folks who regulate what’s in your medicine cabinet say they’re making changes in the way they handle drug safety matters. The Food and Drug Administration is out with a dozen initiatives, in response to a critical report from a group of experts.
WASHINGTON The folks who regulate what’s in your medicine cabinet say they’re making changes in the way they handle drug safety matters. The Food and Drug Administration is out with a dozen initiatives, in response to a critical report from a group of experts.
SAN FRANCISCO (MarketWatch) — The Food and Drug Administration on Tuesday outlined a number of steps to strengthen the safety of the nation’s prescription drugs, part of an ongoing effort prompted, in part, by the withdrawl of the painkiller Vioxx.
WASHINGTON The folks who regulate what’s in your medicine cabinet say they’re making changes in the way they handle drug safety matters. The Food and Drug Administration is…
Atlanta—The Food Safety and Inspection Service, a division of the United States Department of Agriculture, is taking action on various fronts to try to protect the nation’s food supply from possible contamination in the event of an outbreak of avian influenza, according to an agency administrator who spoke at the International Poultry Expo.
The public outcry over the withdrawal of the painkiller Vioxx is leading to closer government scrutiny of new drugs to identify and disclose late-developing safety problems.
Jan. 30 (Bloomberg) — The U.S. Food and Drug Administration pledged to strengthen its monitoring of drug safety in response to a critical report from a panel of advisers.